"in conjunction with Coramsine to achieve the spectacular success against mesothelioma in the recent mouse tests"
Mesothelioma was always the original target - a) seemed to work? and b) had fast track advantages as no alternative existed.
Any ideas why this strategy has been ditched - doesn't work as well as expected or is it more effective against the new melanoma target????
cheers, ob2
- Forums
- ASX - By Stock
- solbec ann phase 2 targets
SBP
solbec pharmaceuticals limited
"in conjunction with Coramsine to achieve the spectacular...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)